chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She is forming a cataract; low grade fever; headaches; body aches; chills; felt miserable; anxiety; This is a spontaneous report from a contactable consumer from a Pfizer-sponsored program support. A female patient of an unspecified age (Age: 69; Unit: Unknown) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported), via an unspecified route of administration on 03Apr2021 at a SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received first dose of COVID vaccine BNT162B2 on 12Mar2021 for COVID-19 immunization and felt a little tired. The patient was scheduled to get an eye examination and her optometrist will be putting some solution to both of her eyes next Tuesday. She wanted to know if she should wait longer because she doesn't want to mess up the vaccine's efficacy. The patient stated that she will be dilated at the optometrist. She was forming a cataract and she did not know if the vaccine would cause the eye exam to be misleading. The patient stated that she read an article that said if you were having a mammogram that you needed to wait two weeks or four weeks. The patient stated she had a low grade fever, headaches, body aches and chills after the second dose of the vaccine. She stated she took Tylenol on the way home after the second dose. She stated that during the nighttime her temperature was creeping up to 100.9. She stated she felt miserable. She stated she took two pills two different times of 500mg each. She stated she took another pill four hours after the first pill because she was miserable and then the temperature started dropping. She stated the symptoms went away after three days. The patient stated that the anxiety was intense for the second dose due to the possible side effects. The patient underwent lab tests and procedures which included body temperature: 100.9 on an unspecified date. Therapeutic measures were taken as a result of low grade fever and felt miserable. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
vaccine expired on 24Sep2023 and was given to a patient today with no reported adverse event; Initial information was received on 27-Sep-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves 35 years old male patient who received diphtheria-2/tetanus-5 adsorbed toxoids NO PRESERVATIVE ADULT [Tenivac] vaccine expired on 24sep2023 and was given to a patient today with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included hepatitis b vaccine; measles vaccine, MUMPS VACCINE, rubella vaccine (MMR); and VARICELLA ZOSTER VACCINE (VARICELLA VACCINE).  On 27-Sep-2023, the patient received a Booster dose of 0.5 ml of suspect diphtheria-2/tetanus-5 adsorbed toxoids NO PRESERVATIVE ADULT (Suspension for injection) (Frequency : Once, lot U7183AA, Expiry date : 24-Sep-2023, strength was unknown) via intramuscular route in the right deltoid for Immunization and vaccine expired on 24sep2023 and was given to a patient today with no reported adverse event (expired product administered) (latency : same day).  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event vaccine expired on 24sep2023 and was given to a patient today with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
A couple days after I received my flu vaccine, I noticed the "lump" in my arm where the medicine was had not gone down.  It was not absorbed fully for almost two weeks. The pain in my right shoulder/arm began approximately Feb. 12th or so.  It radiates down from the shoulder, all the way to my wrist at times, at different strengths, from a constant 2 to a strong 8 or so. Aspirin does not dull the pain.  I cannot raise my right arm over my head, sleep on it or lift things well.  At times it goes almost numb, sending tingling sensations all the way to my fingertips.
dx SLE, systemic vasculitis; glomerulonephritis induced by Heptavax-B vax; extensive documentation abailable upon request; encepalopathy, glomerulopathy, neuropathy; have permanent total disability perforatedintestine NOV92-emergency surger
haven't felt really good; right leg started to collapse ; lost balance; patient went down; Patient felt like leg was made of lead; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (haven't felt really good), BALANCE DISORDER (right leg started to collapse ; lost balance), GAIT DISTURBANCE (patient went down) and LIMB DISCOMFORT (Patient felt like leg was made of lead) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058E21A, 012M20A and 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Cholesterol and Arrhythmia (Heart rhythm).   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Sep-2021, the patient experienced VACCINATION COMPLICATION (haven't felt really good), BALANCE DISORDER (right leg started to collapse ; lost balance), GAIT DISTURBANCE (patient went down) and LIMB DISCOMFORT (Patient felt like leg was made of lead). At the time of the report, VACCINATION COMPLICATION (haven't felt really good), BALANCE DISORDER (right leg started to collapse ; lost balance), GAIT DISTURBANCE (patient went down) and LIMB DISCOMFORT (Patient felt like leg was made of lead) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient is on concomitant medications for bloodthinners, hypertension, cholesterol, heart rhythm. The Patient received the COVID vaccine and flu shot on the same day. No treatment drugs were provided   This case was linked to MOD-2021-012826, MOD-2021-287056 (Patient Link).
Headache & Myalgia Narrative: chills with shaking, arm pain, fatigue and headache
Information has been received from a 70 year old female who was vaccinated with zoster vaccine live (Oka/Merck). Subsequently, the patient experienced redness, warmth, swelling, and itching at injection site. As of 21-MAY-2008, the patient had not recovered. Additional information has been requested.
Chills Muscle aches and pains  Semi-consciousness for 2 days Stomach pain Nausea Diarrhea Weird dreams Fatigue Worst symptoms for 2 days, with fatigue , lethargy, GI symptoms continuing additional 2 days
Reportedly on 11/5/99, the pt experienced congestive heart failure and "kidney shut down" on 11/5 or 11/6/99. The pt was hospitalized and required heart surgery. The pt was discharged from the hospital on 12/9/1999.
shot given 2APR93 & on 13APR93 mom called stating pt had fever up to 105 R for 2 days; also a red rash all over body; felt was MMR reaction;
Intentional deviation from dosage regimen; This spontaneous case was reported by a consumer and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (Intentional deviation from dosage regimen) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INTENTIONAL PRODUCT USE ISSUE (Intentional deviation from dosage regimen). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (Intentional deviation from dosage regimen) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood immunoglobulin G: positive (Positive) Positive and negative (Negative) Negative. On an unknown date, Blood immunoglobulin M: negative (Negative) Negative and negative (Negative) Negative.         Concomitant medications were not provided. Treatment details were not provided.   Reporter did not allow further contact
ITCHY PATCH ON FEET/ ON SHINS/SIDE OF KNEES; PATCHY BURNING RASH ON LOWER BACK/TOP OF BUTTOCKS; SORE ARM; FATIGUE; This spontaneous report received from a patient concerned a 59 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient was very healthy, does not have skin, breathing problems and also not taking any medications. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 12-APR-2021, the subject experienced sore arm. On 12-APR-2021, the subject experienced fatigue. On 16-APR-2021, the subject experienced itchy patch on feet/ on shins/side of knees. On 16-APR-2021, the subject experienced patchy burning rash on lower back/top of buttocks. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fatigue, sore arm, patchy burning rash on lower back/top of buttocks, and itchy patch on feet/ on shins/side of knees. This report was non-serious.
Dizziness, weakness in legs (sporadic but has gone on for 10 days)
On 27 MAR 2021, 9:25 am, I received Janssen vaccine Lot # 1805020 in the left deltoid.  o Later that same afternoon I had upper quadrant abdominal pain, which was partially relieved by resting on the floor on my hands and knees. The pain subsided after a few hours, and I assumed that it was gallbladder related because of a single gallbladder attack' I had over 10 years ago.  o Three days later (30 MAR 2021), while on a Zoom call with a friend, I began to experience more severe upper quadrant abdominal pain and nausea, saying several times over the hour that I thought I might have to vomit. On my return from the bathroom, she tells me that I put my arm up over
Soreness at injection site. On 5/24/2000 and 5/25/2000 had flu-like illness, muscle aches/joint discomfort, most discomfort in back and spine area. Began on 6/1/2000 morning and had discomfort throughout thoracic cage.
After recovering from COVID-19, he had a continued persistent cough that doesn't sound like it has improved at all. He coughs hard enough to the point where he does need to vomit. A couple weeks after he started showing a rash or welts around his knees and after applying a cream to see if it would clear the symptoms up. It did help however the next day it showed up on his shoulders. Symptoms went away. Some welts could be quarter sized and some could be extremely small. We tried to figure out what was causing these allergic reactions. The reaction continued to show clustering in large areas in various places each day. We tried to limit different foods, to see if there were allergies to certain foods or vitamins. He was taking CLARITIN daily and now he is down to just his prescription medication. We were starting research different dyes that may be causing the reaction, and we are starting to see improvement in his symptoms and we believe that he had developed a new allergy to these certain dyes post COVID-19. Symptoms had included overall welts, facial swelling, and coughing are still occurring. Recently with booster shot had no issues.
Dose 1 Pfizer 3/9/21, dose 2 Pfizer 3/30/21, hospitalization for breakthru COVID on 10/24/21 - expected D/C tomorrow, 10/27/21
Seizure activity noted within 30 minutes of vaccination. Pt known to have functional neurologic disorder and pseudoseizures daily (sometimes back-to-back). Pt alert and orientedx4. Pt dizzy and states she did not eat lunch today. Provided with water and granola bar.  Second seizure noted 20 minutes later. Pt stayed for observation for additinal 40 minutes following second seizure. Client refused transportation to hospital and clients brother came to pick her up.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 32 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 07Oct2021 (Lot number: Fc3184) at the age of 32 years as dose 2, single for Covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), administered in arm right, administration date 07Oct2021 (Batch/Lot number: unknown) as dose 1, single. The patient's relevant medical history was not reported. Concomitant medication(s) included: Metoprolol; Metformin; Pantoprazole; Norethindrone Acetate. Vaccination history included: Bnt162b2 (Dose number: 1, product: COVID 19, Brand: Pfizer, Lot number: FC3183, Administration date: 16Sep2021, Administration time: 10:30 AM, Vaccine location: Left arm), administration date: 16Sep2021, when the patient was 32 years old, for COVID-19 immunization. The following information was reported: OFF LABEL USE (non-serious), PRODUCT USE ISSUE (non-serious) all with onset 07Oct2021, outcome "unknown" and all described as "Other vaccine same date vaccine - Influenza 070ct2021"; MUSCULOSKELETAL STIFFNESS (non-serious), NECK PAIN (non-serious) all with onset 07Oct2021 12:00, outcome "recovering" and all described as "Very painful Stiff neck on left side"; NAUSEA (non-serious) with onset 07Oct2021 12:00, outcome "recovering", described as "Nausea". Therapeutic measures were not taken as a result of musculoskeletal stiffness, neck pain, nausea. No follow-up attempts are possible. No further information is expected.
His platelets had dropped to slightly below normal range; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (002191). The reporter is the patient.  A 33 year-old male patient received bnt162b2 (BNT162B2), administration date 17Dec2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Cancer" (unspecified if ongoing), notes: Caller has had cancer in the past and finished his chemotherapy regimen approximately 18 months ago.; "Chemotherapy" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 2), administration date: 27May2021, for COVID-19 immunization; Bnt162b2 (dose 1), for COVID-19 immunization.  The following information was reported: PLATELET COUNT DECREASED (non-serious) with onset Dec2021, outcome "unknown", described as "His platelets had dropped to slightly below normal range". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Five days after receiving his booster dose, he had blood work done and he noted that his platelets had dropped to slightly below normal range. He would like to find out if his decreased platelet value could be attributable to the Pfizer booster vaccine that he recently received.  The lot number for bnt162b2 was not provided and will be requested during follow up.
No additional AE reported; Vaccine coordinator is reporting the administration of improperly stored vaccines to unknown patients after the temperature excursion on 20JAN2022.; This spontaneous report was received from a vaccine coordinator and refers to a patient of unknown age and gender  The patient's pertinent medical history, drug reactions or allergies, and concomitant therapies were not reported.   On an unknown date in 2022,  the patient was vaccinated with measles, mumps, rubella, and varicella (oka-merck) virus vaccine live (recombinant human albumin - rHA) (PROQUAD) subcutaneous injection, lot #U017138, expiration date: 28-NOV-2022, administered for prophylaxis (strength, and route of administration were not provided) that was improperly stored on 20-JAN-2022, and had a temperature excursion of -14C for 7 hours. No additional adverse events reported.   This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2205USA004997: US-009507513-2205USA005002:02167763 US-009507513-2205USA005067:02167763 US-009507513-2205USA005084: US-009507513-2205USA005130: US-009507513-2205USA005071: US-009507513-2205USA005126: US-009507513-2205USA005229:
Information has been received from a physician concerning his daughter, a 13 year old female who on 18-SEP-2008 was vaccinated with the second dose of VARIVAX (lot # 660331/0485X). The patient was also vaccinated with FLUVIRIN on 13-OCT-2008. Subsequently the patient experienced a chicken pox outbreak and had 20 lesions. The patient also had " a local chicken pox like rash" after the first dose of VARIVAX on 18-APR-2007. At the time of the report, the patient was not recovered. The patient sought medical attention by contacting the physician's office. Additional information has been requested.
bad shingles right after their boosters; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, immediately after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 27-Feb-2023 Reporter's comment: The case was received from the consumer via interactive digital media. The reporter asked that mRNA jab. The reporter knew that the patient got bad shingles right after the boosters. Additional supportive information: The follow-up could not be possible as no contact details were available. As per reported information it seems that reporter was reporting about the 2nd dose of Shingles vaccine which was considered as booster of shingles vaccine, therefore single suspect was coded with dose number 2 with immediate time to onset for shingles. This 1 of 3 linked cases reported by same reporter.; Sender's Comments:  US-GSK-US2023AMR036631:Same reporter US-GSK-US2023AMR036632:Same reporter
TOOK LAST DOSE OF VIVOTIF A DAY LATE; This case (PVX2019-2172) was received from a consumer on 26-Aug-2019. It described a female consumer who "took last dose of Vivotif one day late" (PT: Inappropriate schedule of product administration), while being on oral Vivotif for typhoid fever prophylaxis.  Case report: The consumer took the last dose of Vivotif on 24-Aug-2019, instead of 23-Aug-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took last dose of Vivotif one day late" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took last dose of Vivotif one day late" was considered as not applicable.
Sore arm; it's a little red; there's a welt and now there's a second one; Itching in the area; it's a little hot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm), VACCINATION SITE ERYTHEMA (it's a little red), VACCINATION SITE SWELLING (there's a welt and now there's a second one), VACCINATION SITE PRURITUS (Itching in the area) and VACCINATION SITE WARMTH (it's a little hot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore arm), VACCINATION SITE ERYTHEMA (it's a little red), VACCINATION SITE SWELLING (there's a welt and now there's a second one), VACCINATION SITE PRURITUS (Itching in the area) and VACCINATION SITE WARMTH (it's a little hot). At the time of the report, VACCINATION SITE PAIN (Sore arm), VACCINATION SITE ERYTHEMA (it's a little red), VACCINATION SITE SWELLING (there's a welt and now there's a second one), VACCINATION SITE PRURITUS (Itching in the area) and VACCINATION SITE WARMTH (it's a little hot) outcome was unknown.            Treatment for the events were not reported.
Modern a COVID-19 Vacine EUA was received.  Within 2 days my eyes began itching, then sores developed in both upper and lower eyelids. An antibiotic and then an ointment was prescribed.  Conditions still persist nearly 2 months after vaccination.
Arm sore, migraine lasting more than 1 day, fever (>100 F), chills
M.A. gave the patient a booster dose of the Pfizer covid vaccine, when patient was to receive the primary Pfizer covid vaccination.
Pt received hep A, Hep B, Menactra and Tdap on 3/22/07. On 4/6/07 Pt evaluated in office for RUQ ABD pain nausea and vomiting. Labs revealed acute hepatitis. Hep Panel over 3 visits revealed Hepatitis A
Migraine that lasted for four days starting on Sept 17th. Then Covid Arm - red itchy spot at shot location appeared on Sept 24th. Still have the
fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included VITAMINS NOS (DAILY VITAMINS) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced FATIGUE (fatigue). At the time of the report, FATIGUE (fatigue) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported daily vitamin, and declined to list states she is on many medications   This case was linked to MOD-2021-083151 (Patient Link).
The morning after the vaccine, I woke up with rash, swelling and inflammation everywhere that I have eczema and psoriasis. I took prednisone and the symptoms lasted about 24 hours.